Vertex Posts Q3 Loss as Hepatitis Drug Sales Plunge

02.11.2012 - Vertex Pharmaceuticals reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of its Incivek hepatitis C drug, as the company turned its...